AbbVie (ABBV) Approves $1.5B Buyback
AbbVie, Inc. (NYSE: ABBV) authorized a share repurchase program of up to $1.5 billion of the Company's outstanding common stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft (MSFT) Posts Q2 EPS of 71c
- Rush Enterprises (RUSHA) Approves $40M Buyback Plan
- Booz Allen Hamilton (BAH) Raises Quarterly Dividend 18.2% to $0.13; Boosts Buyback to $180M
Create E-mail Alert Related CategoriesStock Buybacks
Related EntitiesStock Buyback
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!